Around 530 people in England living with Duchenne muscular dystrophy (DMD) are set to benefit from a new treatment following the ...
Parents of children with Duchenne muscular dystrophy have spent the 17th night outside the government administration, ...
Investor's Business Daily on MSN
Sarepta dives; can 2026 be the reset year for its controversial gene therapy?
Sarepta stock toppled Thursday as investors digested the better-than-feared sales of its beleaguered gene therapy, Elevidys.
The purpose of this report is to re-evaluate such a therapeutic program in muscular dystrophy when the drugs are used singly, in combination and with or without exercise. Objective serial measurements ...
This study was carried out on 9 patients with myotonic dystrophy and 8 with slowly progressive nonmyotonic muscular dystrophy admitted to the Neurology Service at Duke University Hospital and the ...
The boy showed up with sudden, severe right-sided scrotal pain, swelling, and tenderness after 2–3 days of milder discomfort.
The most commonly diagnosed form of muscular dystrophy, Duchenne is a genetic disease that affects mostly boys and causes progressive muscle weakness over time. Its early physical signs tend to be ...
Georgia’s Health Ministry has expanded state-funded medical services for children with Duchenne Muscular Dystrophy and other ...
Delandistrogene moxeparvovec, a gene therapy for Duchenne muscular dystrophy (DMD), showed high dystrophin expression and a favorable safety profile in young patients. Delandistrogene moxeparvovec ...
Chris Finister, 52, from Evenley, will take part in the Bidwells Oxford 10k this Sunday, May 10, in support of his partner ...
DR. JULIA BELL has contributed a useful monograph on muscular dystrophy in man to “The Treasury of Human Inheritance” series. Clinical and genetical data from more than 1,300 individuals exhibiting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results